ARK Genomic Revolution ETF (BATS:ARKG) Holdings Lowered by ARK Investment Management LLC

ARK Investment Management LLC trimmed its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 52.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,468 shares of the company’s stock after selling 3,872 shares during the period. ARK Investment Management LLC’s holdings in ARK Genomic Revolution ETF were worth $89,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Chris Bulman Inc purchased a new stake in ARK Genomic Revolution ETF in the 2nd quarter worth about $36,000. EverSource Wealth Advisors LLC acquired a new position in ARK Genomic Revolution ETF in the 1st quarter worth about $49,000. Larson Financial Group LLC increased its position in ARK Genomic Revolution ETF by 4,576.1% in the 2nd quarter. Larson Financial Group LLC now owns 3,320 shares of the company’s stock worth $78,000 after purchasing an additional 3,249 shares during the last quarter. First Horizon Advisors Inc. increased its position in ARK Genomic Revolution ETF by 9.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 4,650 shares of the company’s stock worth $109,000 after purchasing an additional 398 shares during the last quarter. Finally, Sanctuary Advisors LLC acquired a new position in ARK Genomic Revolution ETF in the 2nd quarter worth about $222,000.

ARK Genomic Revolution ETF Trading Up 2.0 %

Shares of BATS ARKG opened at $25.90 on Friday. The firm’s 50 day moving average is $24.88 and its 200-day moving average is $25.10.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.